Literature DB >> 6254804

Proteolytic cleavage of exotoxin A from Pseudomonas aeruginosa: formation of an ADP-ribosyltransferase active fragment by the action of Pseudomonas elastase.

Y Sanai, K Morihara, H Tsuzuki, J Y Homma, I Kato.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254804     DOI: 10.1016/0014-5793(80)81063-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   3.864


× No keyword cloud information.
  7 in total

1.  Determination of the regulon and identification of novel mRNA targets of Pseudomonas aeruginosa RsmA.

Authors:  Anja Brencic; Stephen Lory
Journal:  Mol Microbiol       Date:  2009-05       Impact factor: 3.501

2.  Purification and characterization of an extracellular cytolysin produced by Vibrio vulnificus.

Authors:  L D Gray; A S Kreger
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

3.  Characterization of a cellular protease that cleaves Pseudomonas exotoxin.

Authors:  C Fryling; M Ogata; D FitzGerald
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.609

4.  Cloning and expression of a gene segment encoding the enzymatic moiety of Pseudomonas aeruginosa exotoxin A.

Authors:  M A Mozola; R B Wilson; E M Jordan; R K Draper; R C Clowes
Journal:  J Bacteriol       Date:  1984-08       Impact factor: 3.476

5.  A macromolecular structure produced by Pseudomonas aeruginosa is recognized by antibody to exotoxin A.

Authors:  K W Klinger; C W Shuster
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.609

6.  Toxoids of Pseudomonas aeruginosa exotoxin-A: photoaffinity inactivation of purified toxin and purified toxin derivatives.

Authors:  L T Callahan; D Martinez; S Marburg; R L Tolman; D R Galloway
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.609

7.  Effects of proteases on the structure and activity of Pseudomonas aeruginosa exotoxin A.

Authors:  K Morihara; Y Sanai; H Tsuzuki; H Jyoyama; K Hirose; J Y Homma; I Kato
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.609

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.